These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7971611)

  • 1. Helicobacter pylori infection. When and in whom is treatment important?
    Anderson ML
    Postgrad Med; 1994 Nov; 96(6):40-2, 45-50. PubMed ID: 7971611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid peptic diseases in the era of Helicobacter pylori.
    Schoenfeld PS
    Lippincotts Prim Care Pract; 1998; 2(4):358-68. PubMed ID: 9709081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori-negative peptic ulcer. What is its aetiopathogenesis and treatment?
    Monés Xiol J
    Rev Esp Enferm Dig; 2002 Nov; 94(11):687-96. PubMed ID: 12690992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peptic ulcer disease etiology, diagnosis and treatment].
    Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
    Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus development conference on Helicobacter pylori. Revised conclusions and recommendations of the Working group (1999)].
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C95-104. PubMed ID: 10880918
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori and peptic ulcer disease.
    Blum AL
    Scand J Gastroenterol Suppl; 1996; 214():24-7; discussion 42-3. PubMed ID: 8722401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
    Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
    Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
    Howden CW; Leontiadis GI
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori-negative ulcer disease.
    McColl KE
    J Gastroenterol; 2000; 35 Suppl 12():47-50. PubMed ID: 10779218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori: therapeutic targets.
    Louw JA; Marks IN
    Yale J Biol Med; 1998; 71(2):113-7. PubMed ID: 10378356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and peptic ulcer disease.
    Feldman M; Peterson WL
    West J Med; 1993 Nov; 159(5):555-9. PubMed ID: 8279151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The attitude of primary health care physicians in the metropolitan area of Barcelona about the diagnosis and treatment of Helicobacter pylori infection in gastroduodenal diseases].
    Martínez-Sánchez G; Saperas E; Benavent J; Mearin F; Piñol JL; Barenys M; Mascort JJ; Forné M; Bordas JM; Azagra R; Piqué JM
    Gastroenterol Hepatol; 1998 Dec; 21(10):473-8. PubMed ID: 9927791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the treatment of patients with Helicobacter pylori.
    Zullo A; Vaira D
    Am Fam Physician; 2007 Sep; 76(5):633. PubMed ID: 17894129
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.